Liem Esmee Iml, Freund Jan Erik, Baard Joyce, de Bruin D Martijn, Laguna Pes M Pilar, Savci-Heijink C Dilara, van Leeuwen Ton G, de Reijke Theo M, de la Rosette Jean Jmch
Department of Urology, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands.
Department of Biomedical Engineering & Physics, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands.
JMIR Res Protoc. 2018 Feb 7;7(2):e34. doi: 10.2196/resprot.8862.
Visual confirmation of a suspicious lesion in the urinary tract is a major corner stone in diagnosing urothelial carcinoma. However, during cystoscopy (for bladder tumors) and ureterorenoscopy (for tumors of the upper urinary tract) no real-time histopathologic information can be obtained. Confocal laser endomicroscopy (CLE) is an optical imaging technique that allows for in vivo high-resolution imaging and may allow real-time tumor grading of urothelial lesions.
The primary objective of both studies is to develop descriptive criteria for in vivo CLE images of urothelial carcinoma (low-grade, high-grade, carcinoma in situ) and normal urothelium by comparing CLE images with corresponding histopathology.
In these two prospective clinical trials, CLE imaging will be performed of suspicious lesions and normal tissue in the urinary tract during surgery, prior to resection or biopsy. In the bladder study, CLE will be performed in 60 patients using the Cystoflex UHD-R probe. In the upper urinary tract study, CLE will be performed in 25 patients during ureterorenoscopy, who will undergo radical treatment (nephroureterectomy or segmental ureter resection) thereafter. All CLE images will be analyzed frame by frame by three independent, blinded observers. Histopathology and CLE-based diagnosis of the lesions will be evaluated. Both studies comply with the IDEAL stage 2b recommendations.
Presently, recruitment of patients is ongoing in both studies. Results and outcomes are expected in 2018.
For development of CLE-based diagnosis of urothelial carcinoma in the bladder and the upper urinary tract, a structured conduct of research is required. This study will provide more insight in tissue-specific CLE criteria for real-time tumor grading of urothelial carcinoma.
Confocal Laser Endomicroscopy: ClinicalTrials.gov NCT03013894; https://clinicaltrials.gov /ct2/show/NCT03013894?term=NCT03013894&rank=1 (Archived by WebCite at http://www.webcitation.org/6wiPZ378I); and Dutch Central Committee on Research Involving Human Subjects NL55537.018.15; https://www.toetsingonline.nl /to/ccmo_search.nsf/fABRpop?readform&unids=6B72AE6EB0FC3C2FC125821F001B45C6 (Archived by WebCite at http://www.webcitation.org/6wwJQvqWh). Confocal Laser Endomicroscopy in the upper urinary tract: ClinicalTrials.gov NCT03013920; https://clinicaltrials.gov/ct2/show/NCT03013920? term=NCT03013920&rank=1 (Archived by WebCite at http://www.webcitation.org/6wiPkjyt0); and Dutch Central Committee on Research Involving Human Subjects NL52989.018.16; https://www.toetsingonline.nl/to/ccmo_search.nsf/fABRpop?readform&unids=D27C9C3E5755CFECC12581690016779F (Archived by WebCite at http://www.webcitation.org/6wvy8R44C).
对尿路可疑病变进行视觉确认是诊断尿路上皮癌的主要基石。然而,在膀胱镜检查(用于膀胱肿瘤)和输尿管肾镜检查(用于上尿路肿瘤)过程中,无法获得实时组织病理学信息。共聚焦激光显微内镜检查(CLE)是一种光学成像技术,可实现体内高分辨率成像,并可能实现尿路上皮病变的实时肿瘤分级。
两项研究的主要目的都是通过将CLE图像与相应的组织病理学进行比较,制定尿路上皮癌(低级别、高级别、原位癌)和正常尿路上皮的体内CLE图像描述标准。
在这两项前瞻性临床试验中,将在手术切除或活检前对尿路中的可疑病变和正常组织进行CLE成像。在膀胱研究中,将使用Cystoflex UHD-R探头对60例患者进行CLE检查。在上尿路研究中,将在25例输尿管肾镜检查患者中进行CLE检查,这些患者随后将接受根治性治疗(肾输尿管切除术或输尿管节段切除术)。所有CLE图像将由三名独立的、不知情的观察者逐帧分析。评估病变的组织病理学和基于CLE的诊断。两项研究均符合IDEAL 2b期建议。
目前,两项研究都在招募患者。预计2018年得出结果和成果。
为了开发基于CLE的膀胱和上尿路尿路上皮癌诊断方法,需要进行结构化研究。本研究将为尿路上皮癌实时肿瘤分级的组织特异性CLE标准提供更多见解。
共聚焦激光显微内镜检查:ClinicalTrials.gov NCT03013894;https://clinicaltrials.gov /ct2/show/NCT03013894?term=NCT03013894&rank=1(由WebCite存档于http://www.webcitation.org/6wiPZ378I);以及荷兰人类受试者研究中央委员会NL55537.018.15;https://www.toetsingonline.nl /to/ccmo_search.nsf/fABRpop?readform&unids=6B72AE6EB0FC3C2FC125821F001B45C6(由WebCite存档于http://www.webcitation.org/6wwJQvqWh)。上尿路共聚焦激光显微内镜检查:ClinicalTrials.gov NCT03013920;https://clinicaltrials.gov/ct2/show/NCT03013920? term=NCT03013920&rank=1(由WebCite存档于http://www.webcitation.org/6wiPkjyt0);以及荷兰人类受试者研究中央委员会NL52989.018.16;https://www.toetsingonline.nl/to/ccmo_search.nsf/fABRpop?readform&unids=D27C9C3E5755CFECC12581690016779F(由WebCite存档于http://www.webcitation.org/6wvy8R44C)。